Loading company…
Raywatt develops AI-enabled catheter imaging devices for coronary artery diagnostics.
Raywatt develops catheter-based optical coherence tomography imaging devices for coronary arteries, including technology that uses imaging data to predict Fractional Flow Reserve. Founded in 2019, it is based in Seoul, South Korea. In February 2025, it raised KRW 6.5 billion in Series A funding from Industrial Bank of Korea, SBI Investment, L&S Venture Capital, ReInvestment, and OdaStone Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in